Advanced search×

Outcomes after carotid endarterectomy: is there a high-risk population? A National Surgical Quality Improvement Program report.

Jeanwan L JL Kang, Thomas K TK Chung, Robert T RT Lancaster, Glenn M GM Lamuraglia, Mark F MF Conrad, and Richard P RP Cambria

J Vasc Surg 49(2):331-8, 339.e1; discussion 338-9 (2009) PMID 19216952

Carotid endarterectomy (CEA) is the standard treatment of carotid stenosis for symptomatic and asymptomatic patients. Carotid angioplasty and stenting (CAS), however, has been proposed as alternative therapy for patients deemed at high-risk for CEA. This study examined 30-day adjudicated outcomes in a contemporary series of CEAs and assessed the validity of criteria used to define a potential high-risk patient population for CEA.

Copyright © 2009 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.jvs.2008.09.018
Version: za2963e q8za1 q8zb7 q8zcc q8zde q8zeb q8zfd q8zg5

Similar articles you may find interesting…

  1. Does hormone therapy counter the beneficial effects of physical activity on breast cancer risk in postmenopausal women?
    Christina M CM Dieli-Conwright, Jane J Sullivan-Halley, ... Leslie L Bernstein

    Cancer Causes Control 22(3):515-22 (2011) PMID 21213036

    Studies consistently demonstrate that physical activity is inversely associated with postmenopausal breast cancer. Whether this association is stronger among non-hormone users or former users of menopausal hormone therapy (HT) is of interest given the marked decline in HT use since 2...
    View PDF
  2. Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia.
    Michael A MA Peck, Mark F MF Conrad, ... Richard P RP Cambria

    J Vasc Surg 51(1):140-7.e1-2 (2010) PMID 19837530

    Sixty-six mesenteric arteries (78.8% stenotic/21.2% occluded) were treated in 49 patients. One or more vessels were treated in each case; however, four mesenteric artery total occlusions (3 SMAs/1 IMA) could not be crossed. Initial symptom relief was noted in 89.8% (n = 44) with no change in 5 patie...
    View PDF
  3. Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.
    Fiona F See, Tetsunori T Seki, ... Silviu S Itescu

    J Cell Mol Med 15(10):2117-29 (2011) PMID 21155976

    View PDF